Change of Name

RNS Number:0754E
Phoqus Group plc
19 September 2007


                             Change of Company Name

West Malling, UK, 19 September 2007: Phoqus Pharmaceuticals plc (AIM: PQS) 
("Phoqus Pharmaceuticals" or "Company"), the specialty pharmaceuticals drug
development company, announces that following the Company's Extraordinary
General Meeting on 18 September 2007, the Company's name was changed from Phoqus
Group plc to Phoqus Pharmaceuticals plc using the same day procedure of
Companies House on 18 September 2007.

The London Stock Exchange ticker code for the Company remains PQS.

The name of the Company's trading subsidiary, Phoqus Pharmaceuticals Limited,
was changed to Phoqus Pharmaceuticals (UK) Limited on 18 September 2007.

Enquiries:

Phoqus Pharmaceuticals plc          Tel: [phone]
Dr Richard Mason, CEO
Dr Peter Johnson, CFO

Financial Dynamics                  Tel: [phone]
David Yates/John Gilbert

Nomura Code Securities Limited      Tel: [phone]
Phil Walker


Notes to Editors

About Phoqus Pharmaceuticals

Phoqus Pharmaceuticals is a speciality pharmaceutical drug development company
developing secondary care products for patients with significant unmet medical
needs through the use of its proprietary drug delivery and re-formulation
technologies. These allow the company to change the pharmacokinetic profile of
drugs, either improving their therapeutic effect (efficacy and/or safety) in
existing indications, or to change their therapeutic effect so that they may
find use in new indications.

Phoqus Pharmaceuticals' core capability is in oral drug delivery and it has
combined its technology platform with expertise in formulating tablets and
tablet coat powders to create a range of innovative and diverse drug delivery
applications. The Phoqus Pharmaceuticals technology is protected by a
substantial patent portfolio.  Phoqus Pharmaceuticals' underlying technology
platform is based upon electrostatic dry powder deposition. This process
deposits charged powder particles on to the surface of a substrate with high
precision.

Based in Kent, Phoqus Pharmaceuticals was established in 1998 and was admitted
to trading on AIM in November 2005. It is listed under the symbol "PQS".

Further background on the Company can be found at www.phoqus.com.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

CANLPMLTMMBBBMR